Literature DB >> 7975206

Characterization of hepatitis B virus core mutants that inhibit viral replication.

P P Scaglioni1, M Melegari, J R Wands.   

Abstract

We have generated and functionally characterized dominant negative core protein variants of the hepadnaviruses to determine their effects on "wild type" viral replication. Plasmids expressing these constructs were introduced into hepatoma cell lines by transient transfection and effects on wild type woodchuck hepatitis virus (WHV) and hepatitis B virus (HBV) replication were evaluated by Southern blot analysis of purified viral core particles. WHV and HBV constructs expressing a truncated core protein fused in frame with the C-terminus of the small surface protein were found to inhibit viral replication by 90-95% due to disruption of the viral nucleocapsid assembly process and preventing encapsidation of pregenomic RNA. The antiviral effects were found to be specific for the targeted virus. These results demonstrate that mutants of hepadnaviral core protein may represent a novel class of antiviral agents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975206     DOI: 10.1006/viro.1994.1625

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Gene therapeutic approaches to inhibit hepatitis B virus replication.

Authors:  Maren Gebbing; Thorsten Bergmann; Eric Schulz; Anja Ehrhardt
Journal:  World J Hepatol       Date:  2015-02-27

2.  VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication.

Authors:  Jun Yi; Wei-Dong Gong; Ling Wang; Rui Ling; Jiang-Hao Chen; Jun Yun
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

3.  Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50.

Authors:  Brigitte Rupp; Zsolt Ruzsics; Christopher Buser; Barbara Adler; Paul Walther; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

4.  The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.

Authors:  K Fujiwara; O Yokosuka; T Ehata; W L Chuang; F Imazeki; H Saisho; M Omata
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

5.  Posttranscriptional regulation of hepatitis B virus replication by the precore protein.

Authors:  P P Scaglioni; M Melegari; J R Wands
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  A small molecule inhibits and misdirects assembly of hepatitis B virus capsids.

Authors:  Adam Zlotnick; Pablo Ceres; Sushmita Singh; Jennifer M Johnson
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  The cauliflower mosaic virus capsid protein: assembly and nucleic acid binding in vitro.

Authors:  Y Chapdelaine; T Hohn
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

8.  The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice.

Authors:  L G Guidotti; B Matzke; C Pasquinelli; J M Shoenberger; C E Rogler; F V Chisari
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  The 113th and 117th charged amino acids in the 5th alpha-helix of the HBV core protein are necessary for pgRNA encapsidation.

Authors:  Soo Min Lee; Sung Gyoo Park; Esther Park; Jae Yeon Lee; Guhung Jung
Journal:  Virus Genes       Date:  2003-12       Impact factor: 2.332

10.  A defective interference-like phenomenon of human hepatitis B virus in chronic carriers.

Authors:  T T Yuan; M H Lin; D S Chen; C Shih
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.